Article
Direct comparison of the next-generation sequencing and iTERT PCR methods for the diagnosis of TERT hotspot mutations in advanced solid cancers.
BMC medical genomics - 9 Feb 2022
Kang So Young, Kim Deok Geun, Kim Hyunjin, Cho Yoon Ah, Ha Sang Yun, Kwon Ghee Young, Jang Kee-Taek, Kim Kyoung-Mee
Abstract excerpt
BACKGROUND: Mutations in the telomerase reverse transcriptase (TERT) promoter region have been proposed as novel mechanisms for the transcriptional activation of telomerase. Two recurrent mutations in the TERT promoter, C228T and C250T, are prognostic biomarkers. Herein, we directly compared the commercially available iTERT PCR kit with NGS-based deep sequencing to validate the NGS results and determine the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
